Because palmitoylation is a dynamic, post-translational process, it is believed to be employed by the cell to alter the subcellular localization, proteinprotein interactions, or binding capacities of a protein
New data is continuously emerging, so the options could change
Some systematic reviews and meta-analyses have suggested potential benefits for glycaemic control and modest weight reduction
To view or add a comment, sign in Results from a phase 2 study evaluating an investigational treatment for Alpha-1 Antitrypsin Deficiency (#AATD) have successfully achieved all primary and key secondary endpoints
Our results demonstrate that the effects of once-weekly semaglutide 2.4 mg after MBS are in line with the reported safety and tolerability profile
Treating that changes everything, with or without a GLP-1